New Technologies for Treatment of Benign Prostatic Hyperplasia (2021)
Dean Elterman, MD, MS, FRCSC, Bruce Gao, MD, Steven Lub, Naeem Bhojani, MD, FRCSC, Kevin C. Zorn, MD, FRCSC, Bilal Chughtai, MD
INTRODUCTION
Benign prostatic hyperplasia (BPH) is a ubiquitous disease that affects 50% of...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.